BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $151 | -98.3% | 3 | -97.9% | 0.00% | -100.0% |
| Q2 2023 | $8,975 | +6548.1% | 142 | +4633.3% | 0.00% | – |
| Q1 2023 | $135 | -89.7% | 3 | -90.0% | 0.00% | – |
| Q4 2022 | $1,314 | +31.4% | 30 | +42.9% | 0.00% | – |
| Q3 2022 | $1,000 | -66.7% | 21 | -69.6% | 0.00% | – |
| Q2 2022 | $3,000 | +200.0% | 69 | +666.7% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 9 | -35.7% | 0.00% | – |
| Q4 2021 | $1,000 | -75.0% | 14 | -65.0% | 0.00% | -100.0% |
| Q3 2021 | $4,000 | +300.0% | 40 | +344.4% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 9 | -64.0% | 0.00% | – |
| Q1 2021 | $2,000 | – | 25 | +525.0% | 0.00% | – |
| Q4 2020 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 4 | -99.6% | 0.00% | -100.0% |
| Q1 2020 | $56,000 | +600.0% | 969 | +822.9% | 0.01% | +800.0% |
| Q4 2019 | $8,000 | -69.2% | 105 | -70.8% | 0.00% | -75.0% |
| Q3 2019 | $26,000 | -21.2% | 359 | 0.0% | 0.00% | -20.0% |
| Q2 2019 | $33,000 | – | 359 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
| DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
| Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
| Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
| Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
| CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
| Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
| EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |